Viavi Solutions is trading at $32.60, down 6.80% versus the October 19 close, with no clear, confirmed catalyst identified for the pre-market decline.
- An October 20 article reports the U.S. Army selected Viavi Solutions’ T/Rx system and expanded its Calnex partnership; neither is linked to the decline.
- The company’s next results are scheduled for November 4, not before this session.
- Major indices show mixed, modest moves, offering no clear broad-market explanation.